Recent Advantage of Hyaluronic Acid for Anti-cancer Application: a Review of "3S" Transition Approach
Overview
Affiliations
In recent years, nano drug delivery system has been widely concerned because of its good therapeutic effect. However, the process from blood circulation to cancer cell release of nanodrugs will be eliminated by the human body's own defense trap, thus reducing the therapeutic effect. In recent years, a "3S" transition concept, including stability transition, surface transition and size transition, was proposed to overcome the barriers in delivery process. Hyaluronic (HA) acid has been widely used in delivery of anticancer drugs due to its excellent biocompatibility, biodegradability and specific targeting to cancer cells. In this paper, the strategies and methods of HA-based nanomaterials using "3S" theory are reviewed. The applications and effects of "3S" modified nanomaterials in various fields are also introduced.
Gralewska P, Gajek A, Marczak A, Rogalska A Int J Mol Sci. 2024; 25(15).
PMID: 39125873 PMC: 11312858. DOI: 10.3390/ijms25158304.
Polymer-Based Drug Delivery Systems for Cancer Therapeutics.
Ding L, Agrawal P, Singh S, Chhonker Y, Sun J, Murry D Polymers (Basel). 2024; 16(6).
PMID: 38543448 PMC: 10974363. DOI: 10.3390/polym16060843.
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
Shi P, Cheng Z, Zhao K, Chen Y, Zhang A, Gan W J Nanobiotechnology. 2023; 21(1):103.
PMID: 36944946 PMC: 10031984. DOI: 10.1186/s12951-023-01826-1.
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery.
Chaudhary B, Kumar P, Arya P, Singla D, Kumar V, Kumar D Curr Drug Metab. 2023; 23(13):1027-1053.
PMID: 36627789 DOI: 10.2174/1389200224666230110145513.
Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?.
Machado V, Morais M, Medeiros R Pharmaceutics. 2022; 14(10).
PMID: 36297526 PMC: 9609123. DOI: 10.3390/pharmaceutics14102092.